Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
29.05.24
/
50%
€46.00
Target price
29.05.25
€68.37
Performance (%)
50.00%
Price
25.07.24
€68.00
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Insmed Inc. has seen massive gains of 50.00%. This prediction currently runs until 29.05.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.857% | -2.857% |
| iShares Core DAX® | 1.280% | 1.320% |
| iShares Nasdaq 100 | -2.457% | -5.192% |
| iShares Nikkei 225® | -2.006% | -1.389% |
| iShares S&P 500 | -0.662% | -1.884% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat